The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor
Abstract
Human papillomavirus type 16 (HPV16) and other high-risk HPVs are etiologically linked to the development of cervical carcinomas and contribute to a number of other tumors of the anogenital tract, as well as oral cancers. The high-risk HPV E6 and E7 oncoproteins are consistently expressed in cervical cancer cells and are necessary for the induction and maintenance of the transformed phenotype. An important aspect of HPV16 E7's oncogenic activities is destabilization of the retinoblastoma tumor suppressor (pRB) through a ubiquitin/proteasome-dependent mechanism, although the exact molecular mechanism is unknown. Here, we report that HPV16 E7 is associated with an enzymatically active cullin 2 ubiquitin ligase complex and that the HPV16 E7/pRB complex contains cullin 2. Depletion of cullin 2 by RNA interference causes increased steady-state levels and stability of pRB in HPV16 E7-expressing cells, and ectopic expression of HPV16 E7 and the cullin 2 complex leads to pRB ubiquitination in vivo. Hence, we propose that the HPV16 E7-associated cullin 2 ubiquitin ligase complex contributes to aberrant degradation of the pRB tumor suppressor in HPV16 E7-expressing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“high-risk HPV-16 E7 can destabilize pRB [127,128] through proteasomal degradation by interacting with the cullin 2 ubiquitin ligase complex [129]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
Pocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601
Research works printed but not linked: 66
- 10.1128/JVI.78.6.2749-2757.2004 · DOI
- An, B., and Q. P. Dou. 1996. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res.56:438-442.
- 10.1128/JVI.02497-05 · DOI
- 10.1128/JVI.79.17.11392-11402.2005 · DOI
- Banks, L., C. Edmonds, and K. Vousden. 1990. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH 3T3 cells. Oncogene5:1383-1389.
- Barry, M., and K. Fruh. 2006. Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci. STKE2006:pe21.
- 10.1038/sj.onc.1200872 · DOI
- 10.1074/jbc.272.48.30135 · DOI
- Berezutskaya, E., B. Yu, A. Morozov, P. Raychaudhuri, and S. Bagchi. 1997. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ.8:1277-1286.
- 10.1128/MCB.24.21.9619-9629.2004 · DOI
- Boyer, S. N., D. E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res.56:4620-4624.
- 10.1371/journal.ppat.0020116 · DOI
- 10.1073/pnas.89.10.4549 · DOI
- 10.2174/1389203043379783 · DOI
- 10.1128/JVI.79.23.14769-14780.2005 · DOI
- 10.1016/0092-8674(88)90559-4 · DOI · Paper page
- 10.1093/emboj/cdg190 · DOI
- 10.1128/jvi.63.6.2650-2656.1989 · DOI
- 10.1128/JVI.02303-06 · DOI
- 10.1128/MCB.20.21.8185-8197.2000 · DOI
- 10.1093/jnci/92.9.709 · DOI
- 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
- 10.1038/sj.onc.1207413 · DOI
- 10.1128/JVI.76.18.9194-9206.2002 · DOI
- 10.1128/JVI.75.15.6737-6747.2001 · DOI · Paper page
- 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- 10.1016/S0959-437X(01)00265-9 · DOI
- 10.1038/71600 · DOI
- 10.1073/pnas.0505337102 · DOI · Paper page
- 10.1073/pnas.92.7.2563 · DOI
- Human papillomaviruses 1995 vol. 64
- 10.1128/jvi.71.4.2905-2912.1997 · DOI · Paper page
- 10.1006/viro.1997.8851 · DOI · Paper page
- 10.1128/MCB.23.6.1885-1895.2003 · DOI
- 10.1073/pnas.0538058100 · DOI
- 10.1101/gad.1252404 · DOI
- 10.1128/JVI.79.18.11685-11692.2005 · DOI
- 10.1093/emboj/20.15.4003 · DOI
- 10.1038/sj.onc.1208105 · DOI
- 10.1073/pnas.0503886102 · DOI
- 10.1158/0008-5472.CAN-03-3566 · DOI
- 10.1128/JVI.78.21.11451-11460.2004 · DOI · Paper page
- 10.1002/j.1460-2075.1989.tb08594.x · DOI · Paper page
- 10.1016/S0167-4781(96)00210-2 · DOI
- 10.1128/JVI.78.10.5338-5346.2004 · DOI
- 10.1038/sj.onc.1207414 · DOI
- 10.1128/jvi.66.4.2418-2427.1992 · DOI · Paper page
- 10.1016/0092-8674(88)90570-3 · DOI · Paper page
- Piboonniyom, S., S. Duensing, N. W. Swilling, P. W. Hinds, and K. Münger. 2003. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res.63:476-483.
- 10.1146/annurev.biochem.70.1.503 · DOI · Paper page
- 10.1101/gad.926401 · DOI
- Riley, R. R., S. Duensing, T. Brake, K. Munger, P. F. Lambert, and J. M. Arbeit. 2003. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res.63:4862-4871.
- 10.1016/0092-8674(93)90384-3 · DOI · Paper page
- 10.1016/0092-8674(90)90409-8 · DOI · Paper page
- 10.1074/jbc.273.11.6439 · DOI
- 10.1128/MCB.25.16.7120-7136.2005 · DOI
- 10.1101/gad.1011202 · DOI
- 10.1038/sj.onc.1207442 · DOI · Paper page
- Vousden, K. H., and P. S. Jat. 1989. Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene4:153-158.
- 10.1038/334124a0 · DOI · Paper page
- 10.1038/ncb1203-1029 · DOI
- 10.1128/jvi.67.4.2402-2407.1993 · DOI · Paper page
- 10.1074/jbc.M004847200 · DOI
- 10.1126/science.1089591 · DOI
- 10.1073/pnas.0510012103 · DOI · Paper page
- 10.1038/nrc798 · DOI
Cited by
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex
Bussiere, D. E., Xie, L., Srinivas, H., Shu, W., Burke, A., Be, C., Zhao, J., Godbole, A., King, D., Karki, R. G., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-019-0411-6 · Cited by 257
White, E. A., Sowa, M. E., Tan, M. J. A., Jeudy, S., Hayes, S. D., Santha, S., Münger, K., Harper, J. W., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116776109 · Cited by 198
Self-citationBasukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Cullin E3 Ligases and Their Rewiring by Viral Factors
Mahon, C., Krogan, N., Craik, C., & Pick, E. (2014) · Biomolecules · doi:10.3390/biom4040897 · Cited by 101
E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
Lou, Z., & Wang, S. (2014) · Journal of International Medical Research · doi:10.1177/0300060513506655 · Cited by 22
From serendipity to strategy: molecular glue degraders in cancer therapeutics
Darling, S., Bajrami, I., & West, S. C. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2564068 · Cited by 9
“For HPv, induced degradation of retinoblastoma protein (Rb) results in oncogenic transformation (Huh et al. 2007).”
Metadata
- Authors
- Huh, K., Zhou, X., Hayakawa, H., Cho, J.-Y., Libermann, T. A., Jin, J., Wade Harper, J., & Munger, K.
- Affiliations
- The Channing Laboratory, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
- Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu 700-422, South Korea
- Beth Israel Deaconess Medical Center Genomics Center and Bioinformatics Core, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115
- Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-09-15
- Volume
- 81
- Issue
- 18
- Pages
- 9737-9747
- ISSN
- 0022-538X
- 1098-5514
- Cited by
- 259
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review